the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images


September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector Systems (CT Injector, MRI Injector), Consumables (Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) - Global Forecast to 2025," published by MarketsandMarkets, the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025.

Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the market. However, the high cost of contrast media injectors and consumables and accessories is restraining the growth of the market to a certain extent.

The consumables segment accounted for the largest share of the contrast media injection market, by type, in 2019. Based on the product, the contrast media injectors market is segmented into injector systems, consumables and accessories. The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors. The consumables segment is segmented further into syringes, tubes, other consumables. In 2019, the consumables segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. These consumables need to be re-purchased for every new procedure, as opposed to instruments, thus driving its demand.

The interventional cardiology segment to register the highest CAGR in the market during the forecast period. Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. In 2019, the interventional cardiology segment had the highest growth rate of the market. The rising prevalence of CVD is driving the growth of this application segment.
The hospital segment will continue to dominate the contrast media injector end-user market during the forecast period. Based on end-user, the market is segmented into hospitals and diagnostic imaging centers. The hospital segment commanded the highest growth rate of the global market in 2019. The high growth rate of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals and the growing inclination of hospitals towards the automation and digitization of radiology patient workflow.

For more information: www.marketsandmarkets.com


Related Content

Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
Feature | Radiology Business | By William T. Thorwarth Jr., MD, FACR

As we witness a mounting backlash against prior authorization in healthcare, we must explore more effective alternatives ...

Time May 02, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Feature | Information Technology | By Melinda Taschetta-Millane

The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought ...

Time May 01, 2024
arrow
News | FDA

April 30, 2024 — International medical imaging IT and Cybersecurity company Sectra’s digital pathology solution together ...

Time April 30, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Feature | Breast Imaging | By Christine Book

From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...

Time April 29, 2024
arrow
Subscribe Now